Serological diagnosis of Dengue virus infection in travellers; the impact of cross-reacting flaviviridae antigens.

Serological diagnosis of Dengue virus infection in travellers; the impact of cross-reacting flaviviridae antigens. - Cross-reacivity in Dengue IgG serology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37829

Enrollment

Registered

2012-05-24

Start date

2012-07-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breakbone fever

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The research population is defined as healthy volunteers (>18-years old) who received a Yellow Fever vaccination or a Tick Born Encephalitis vaccination.

Exclusion criteria

Exclusion criteria: Immuno-compromised patients or pregnancy. Patients with known coagulopathias.

Design outcomes

Primary

Measure	Time frame
The main parameter is specificity and positive predictive value of the Dengue IgG ELISA.	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results